Search Result "Bcr-Abl associated leukemias"
Life and Death of Leukemic Cells Under Bcr-Abl Signaling Control
Journal: Current Cancer Therapy Reviews
Volume: 5 Issue: 4 Year: 2009 Page: 303-309
Author(s): Junya Kuroda, Masafumi Taniwaki
Targeting BCR-ABL Oncoprotein for Leukemia Therapy: Current Biotechnology and Future Perspectives
Journal: Current Biotechnology
Volume: 1 Issue: 2 Year: 2012 Page: 175-183
Author(s): Min Shen,Q. Ping Dou
BCR-ABL Inhibitors in Chronic Myeloid Leukemia: Process Chemistry and Biochemical Profile
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 2943-2959
Author(s): F. Leonetti, A. Stefanachi, O. Nicolotti, M. Catto, L. Pisani, S. Cellamare, A. Carotti
Unleashing the Guardian: The Targetable BCR-ABL/HAUSP/PML/PTEN Network in Chronic Myeloid Leukemia
Journal: Current Drug Targets
Volume: 18 Issue: 4 Year: 2017 Page: 389-395
Author(s): Alessandro Morotti,Davide Torti,Giovanna Carra,Cristina Panuzzo,Sabrina Crivellaro,Riccardo Taulli,Carmen Fava,Angelo Guerrasio,Giuseppe Saglio
Effects of BCR-ABL Inhibitors on Anti-Tumor Immunity
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 3 Year: 2011 Page: 5174-5184
Author(s): M. Krusch, H. R. Salih
Screening and Activity Evaluation of Novel BCR-ABL/T315I TyrosineKinase Inhibitors
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 20 Year: 2024 Page: 2872-2894
Author(s):
Recent Developments in the Third Generation Inhibitors of Bcr-Abl for Overriding T315I Mutation
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 2146-2157
Author(s): X. Y. Lu, Q. Cai, K. Ding
Second Generation Abl Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 1 Issue: 3 Year: 2006 Page: 347-355
Author(s): Shinya Kimura
Second Generation Abl Tyrosine Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone (Second Edition)
Ebook: Frontiers in Anti-Cancer Drug Discovery
Volume: 1 Year: 2010
Author(s): Shinya Kimura
Doi: 10.2174/978160805161811001010116
Nilotinib Therapy in Chronic Myelogenous Leukemia: The Strength of High Selectivity on BCR/ABL
Journal: Current Drug Targets
Volume: 10 Issue: 6 Year: 2009 Page: 530-536
Author(s): Massimo Breccia, Giuliana Alimena